Isordil
Isordil
- In our pharmacy, you can buy isordil without a prescription, with delivery available throughout Canada; discreet packaging and anonymous shipping are offered. Note that in many regulated markets isosorbide dinitrate is officially prescription-only and you should follow local laws and medical advice.
- Isordil (isosorbide dinitrate) is used to prevent and treat angina pectoris; it is a nitrate vasodilator that releases nitric oxide, causing vascular smooth muscle relaxation, venodilation (reducing preload) and coronary vasodilation to improve myocardial oxygen supply.
- Usual doses: acute sublingual dose 2.5–5 mg at onset of chest pain; chronic immediate‑release dosing typically 5–20 mg two to three times daily (titrate to response); extended‑release formulations commonly 20–40 mg once daily—allow a nitrate‑free interval (about 12–14 hours) to reduce tolerance.
- Administration forms: sublingual tablets (2.5 mg, 5 mg, 10 mg), oral immediate‑release tablets (5–40 mg strengths), and extended‑release oral tablets (typically 20 mg and 40 mg).
- Onset of action: sublingual doses usually begin to work within 1–3 minutes; oral immediate‑release preparations typically start within 15–30 minutes (extended‑release forms take longer).
- Duration of action: sublingual effect commonly lasts about 30–60 minutes; oral immediate‑release effects about 4–6 hours; extended‑release formulations may provide effect for approximately 8–12 hours—tolerance can shorten effectiveness if dosed continuously.
- Alcohol warning: avoid alcohol while taking isordil, as alcohol can potentiate blood‑pressure lowering effects and increase the risk of severe dizziness, fainting or syncope.
- The most common side effect is headache; other frequent effects include dizziness, flushing, weakness and postural hypotension—serious adverse effects include severe hypotension and syncope.
- Would you like to try isordil without a prescription?
Basic Isordil Information
- INN (International Nonproprietary Name): Isosorbide dinitrate
- Brand Names Available In Canada (English): not specified
- ATC Code: C01DA08
- Forms & Dosages: Sublingual tablets 2.5 mg, 5 mg, 10 mg; Immediate-release oral tablets 5–40 mg; Extended-release tablets 20 mg and 40 mg
- Manufacturers In Canada (English): not specified
- Registration Status In Canada (English): not specified
- OTC / Rx Classification: Prescription Only (Rx)
Availability & Price Landscape
Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)
Where will Canadians usually find isosorbide dinitrate?
Isosorbide dinitrate is prescription-only in regulated markets and is carried mainly as generics at national and regional chains.
Stocking depends on provincial formularies and wholesaler supply, so a product available in one province may be out of stock in another.
Isordil as a US brand is discontinued, but generics and international brands appear intermittently through wholesalers and suppliers.
- Shoppers Drug Mart — large national footprint, in-store prescription transfer and pharmacist counselling widely available.
- Rexall — similar retail services with pharmacy counselling and variable stock by province.
- London Drugs — strong presence in Western Canada, pharmacist-led counselling and in-store prescription transfers.
- Jean Coutu — common in Quebec for francophone regions, provincial coverage and local formularies affect stocking.
Online Pharmacy Trends In Canada (Including Provincial Restrictions)
How do online Canadian pharmacies handle isosorbide dinitrate orders?
Online Canadian pharmacies most often sell generics and are regulated by provincial pharmacy colleges, which set rules about shipping and prescription verification.
Many online pharmacies require an electronic or faxed prescription before dispensing a nitrate product.
Provincial shipping limits and controlled-substance rules may apply, so availability online varies by province.
Cross-border purchases from the United States or India occur, but these raise customs and regulatory issues and may lack a Canadian DIN.
In our online pharmacy, isordil is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.
Note that regulated markets list isosorbide dinitrate as prescription-only and pharmacists must verify prescriber information and DIN when dispensing.
Price Ranges By Package Size (With Provincial Differences)
What will it cost at retail in Canada?
Typical retail estimates for generic isosorbide dinitrate vary by strength, pack size and province because provincial coverage affects out-of-pocket cost.
Small sublingual bottles or blister strips (packs of 100 or 1×10 strips depending on supplier) commonly range from about CAD 10 to CAD 60 depending on strength and retailer.
Extended-release tablets are generally higher priced than immediate-release formulations because of manufacturing costs and pack size.
Provincial drug plans such as Ontario Drug Program (ODP), BC PharmaCare and RAMQ may cover specific DINs, which reduces patient cost where listed.
| Pack / Strength | Typical Retail Range (CAD) | Provincial Notes |
|---|---|---|
| Sublingual 2.5–5 mg (bottle of 100) | 10–35 | Coverage depends on DIN listing in provincial formulary |
| Immediate-Release 5–20 mg (blister or bottle) | 15–45 | Out-of-pocket varies; bulk packs sometimes cheaper |
| Extended-Release 20–40 mg (packs) | 30–60+ | Higher cost; may be preferred for adherence |
Canadian Patient Insights & Satisfaction Levels
Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)
What are Canadians saying on forums about isosorbide dinitrate?
Discussions appear on Reddit r/CanadaHealthcare, HealthBoards and condition-focused threads, with common themes around access and side effects.
- Access and prescription renewals — patients ask how to transfer prescriptions or get emergency refills when travelling between provinces.
- Tolerability — frequent reports of headaches, dizziness and concerns about stopping therapy because of side effects.
- Switching between nitrate products — questions about differences between isosorbide dinitrate and isosorbide mononitrate.
- “I got a pounding headache the first week after switching brands, pharmacist suggested spacing doses.” — anonymized example.
- “My provincial plan covered the generic, which made it affordable.” — anonymized example.
- “Ordering from an e-pharmacy saved money but I wasn’t sure about the manufacturer.” — anonymized example.
Reported Benefits And Challenges From Canadian Patients
Which real benefits and problems do patients share?
- Benefit — Reliable Acute Relief
- Sublingual tablets deliver quick relief for angina attacks when available and taken correctly.
- Benefit — Affordable Generics
- Patients note low cost when a DIN-listed generic is covered by provincial plans.
- Challenge — Headaches And Dizziness
- Vasodilatory side effects often prompt dose changes or temporary discontinuation.
- Challenge — Tolerance With Frequent Dosing
- Patients describe needing a nitrate-free interval to maintain effect and avoid tolerance.
- Challenge — Sourcing Specific Formulations
- Difficulty finding extended-release or sublingual forms locally leads some to compare in-store and online prices or import international generics.
Product Overview & Brand Variants
INN And Brand Names Used In Canada
What labels and packs should Canadians expect?
The International Nonproprietary Name is isosorbide dinitrate and ATC C01DA08 classifies it among cardiac vasodilators.
The US brand Isordil is discontinued, but generic versions and international brands such as Isoket and other regional names appear through wholesalers.
Common pack types include sublingual 2.5 mg, 5 mg and 10 mg; immediate-release 5–40 mg; and extended-release 20 mg and 40 mg tablets.
Manufacturers that commonly export generics internationally include IPCA Pharmaceuticals, Kachhela Medex and Zydus Pharmaceuticals.
Legal Classification Under Health Canada
How is isosorbide dinitrate classified for dispensing?
Isosorbide dinitrate is Prescription Only (Rx) in regulated markets and product marketing in Canada is controlled through DINs where available.
| Product Form | Typical Strengths | DIN Presence |
|---|---|---|
| Sublingual Tablet | 2.5 mg, 5 mg, 10 mg | Likely DIN required; verify at time of dispensing |
| Immediate-Release Oral Tablet | 5–40 mg | Likely DIN required; check provincial listings |
| Extended-Release Tablet | 20 mg, 40 mg | Likely DIN required; product-specific lookup advised |
Indications In Local Canadian Medical Practice
Approved Uses (Health Canada DIN Context)
What is isosorbide dinitrate approved for?
Primary approved indication is prevention and relief of angina pectoris, with sublingual forms used for acute attacks and oral or extended-release forms used for prophylaxis.
Clinicians follow product monographs and DIN-based labels but also consult cardiology guidelines when adjusting regimens for individual patients.
Off-Label Patterns In Canadian Healthcare
Are there off-label uses clinicians sometimes consider?
Off-label usage is uncommon but can include tailored symptomatic relief in heart failure when combined with other agents such as hydralazine in selected patients.
- Off-label Scenario — Palliative vasodilation in end-of-life care with clear documentation and specialist endorsement.
- Off-label Scenario — Adjunctive therapy in specific heart-failure regimens where cardiology guidance supports the choice.
Off-label use should be documented in the chart and, where appropriate, discussed with a specialist.
How It Works In The Body
Layman’s Explanation (Canadian Patient-Friendly Tone)
How does isosorbide dinitrate ease chest pain?
The drug converts to nitric oxide in the body and relaxes blood vessels so the heart pumps against less pressure.
That reduced workload means the heart needs less oxygen, which eases angina symptoms.
Sublingual tablets act quickly for sudden attacks and oral or extended-release tablets act more slowly to prevent angina.
Clinical Detail From Health Canada Resources
What does the pharmacology tell clinicians?
Nitrate-derived nitric oxide primarily causes venodilation which reduces preload, and at higher doses causes arterial dilation which reduces afterload.
Health Canada monographs and pharmacology sources note rapid absorption for sublingual tablets and variable oral bioavailability due to first-pass hepatic metabolism.
Clinicians use these pharmacokinetic differences to choose sublingual forms for rapid relief and oral or extended-release forms for maintenance therapy.
Dosage & Administration
Standard Regimens Per Canadian Guidelines
What dosing patterns are commonly used?
For prevention, immediate-release oral dosing typically starts at 5–20 mg two to three times daily and is titrated to effect and tolerability.
For an acute attack, sublingual 2.5–5 mg is placed under the tongue at onset and repeated per clinical guidance if needed.
Extended-release tablets (20–40 mg) are used for once- or twice-daily prophylaxis depending on patient response and product monograph instructions.
Always follow the DIN product monograph and prescriber directions when dispensing.
Adjustments By Patient Type (With Canadian Clinical Notes)
Who needs special dosing attention?
| Patient Type | Typical Dose | Canadian Clinical Note |
|---|---|---|
| Elderly | Start at lower end (eg, 5 mg) | Increased sensitivity; monitor blood pressure closely |
| Renal/Hepatic Impairment | No formal adjustment | Use caution and monitor for prolonged effect or hypotension |
| Children | Not established | Generally not recommended in pediatric populations |
| General Tip | Nitrate-Free Interval | Allow 12–14 hours nitrate-free daily to reduce tolerance |
Contraindications & Side Effects
Common (Health Canada-Approved List)
What problems do patients often see?
Common adverse effects include headache, dizziness, flushing and weakness.
Postural hypotension and tachycardia can occur and should be counselled for.
Absolute contraindications in product monographs include hypersensitivity to nitrates and concurrent use with PDE5 inhibitors such as sildenafil and tadalafil.
Rare But Serious (With Canadian Pharmacovigilance Data)
What rare but critical reactions deserve screening?
- Contraindication — Concurrent PDE5 Use
- Can cause profound and dangerous hypotension; pharmacists must screen for sildenafil, tadalafil or related agents.
- Side Effect — Severe Hypotension / Syncope
- Rare reports exist in vigilance databases and require emergency care and stopping the drug.
- Side Effect — Severe Allergic Reaction
- Occasional; treat per standard anaphylaxis protocols if suspected.
Comparable Medicines In Canada
Alternatives Table (With DIN References)
What other drugs do prescribers choose instead of isosorbide dinitrate?
| Alternative | Class | Typical Advantage | Notes / DIN |
|---|---|---|---|
| Isosorbide Mononitrate | Nitrate Vasodilator | Once-daily dosing, less first-pass effect | DIN lookup required at time of dispensing |
| Glyceryl Trinitrate (Nitroglycerin) | Nitrate | Very rapid onset for acute attacks | Common acute-care agent; DIN varies by formulation |
| Nicorandil | Potassium Channel Opener / Nitrate | Alternative antianginal for selected patients | Availability varies by market; check DIN |
Pros And Cons List
- Pros — Established efficacy for angina, available in sublingual and oral forms, cost-effective generics often available.
- Cons — Multiple daily dosing for immediate-release forms, risk of tolerance and prominent headaches for some patients.
- Consideration — Isosorbide mononitrate may be preferred for simpler dosing and reduced first-pass metabolism; nitroglycerin is typically chosen for fastest relief of acute chest pain.
Current Research & Trends
Major Canadian Or International Studies 2022–2025
What recent studies affect clinical use?
Recent research has focused on optimising nitrate regimens to limit tolerance and on combination therapies such as hydralazine plus nitrates for heart-failure subsets.
Bidil's history (hydralazine plus isosorbide dinitrate) informs ongoing interest in combination therapy for selected patients with heart failure.
Canadian centres contribute to comparative studies, but larger international meta-analyses often drive guideline updates.
Practical Implications For Pharmacists And Prescribers
How should clinicians act on recent trends?
Pharmacists should prioritise adherence counselling, monitor for nitrate tolerance, and suggest extended-release formulations when appropriate to improve tolerability.
Watch for supply changes from international manufacturers such as IPCA and Zydus, and verify DINs when new generics enter the market.
Common Patient Questions In Canada
Grouped Q&A Format
- Q: Is a prescription required in Canada?
- A: Yes — Rx required; pharmacists verify DIN and prescriber information before dispensing.
- Q: Can I take sildenafil with ISDN?
- A: No — concurrent use with phosphodiesterase type 5 inhibitors is contraindicated due to risk of dangerous hypotension.
- Q: Why do I get headaches?
- A: Headaches are a common vasodilatory side effect and may improve with time or dose adjustment; consult the prescriber or pharmacist.
- Q: What if I run out while travelling between provinces or to the US?
- A: Request an emergency refill from a pharmacist and check provincial rules; cross-border purchases carry regulatory and customs risk and may lack a Canadian DIN.
- Q: How should I take sublingual tablets in an attack?
- A: Place 2.5–5 mg under the tongue at onset and follow prescriber instructions for repetition; seek urgent care if pain persists.
- Q: How do I avoid tolerance?
- A: Use the nitrate-free interval (generally 12–14 hours per day) as recommended to limit tolerance.
- Q: Can elderly patients take the same dose as younger adults?
- A: Start at the low end of dosing due to increased sensitivity and monitor blood pressure.
- Q: Where can I find the most affordable option?
- A: Compare in-store prices at chains and provincial coverage; DIN-listed generics may be covered by provincial plans and reduce cost.
Regulatory Status
Health Canada Approval Process
How are nitrate products regulated for sale in Canada?
Health Canada requires evidence of safety, efficacy and quality for a product to receive a Drug Identification Number (DIN) and market authorization.
Many isosorbide dinitrate preparations are marketed as generics under DINs in different jurisdictions; verify active DINs at time of dispensing.
DIN Number Relevance
Why does the DIN matter for patients and pharmacies?
A DIN uniquely identifies formulation, strength and manufacturer and is required for reimbursement and pharmacovigilance reporting.
Provincial drug plans often require the DIN for listing and reimbursement, so a DIN lookup is necessary when checking coverage under ODP, BC PharmaCare or RAMQ.
Visual Recommendations
Infographic Ideas For Canadian Context
What visuals help patients understand isosorbide dinitrate?
- "How ISDN Works" panel showing vessel dilation and reduced heart workload with simple labels.
- "How To Take Sublingual Tablet" step-by-step images that show placing the tablet under the tongue and not swallowing immediately.
- "What To Tell Your Pharmacist" checklist including current meds, PDE5 inhibitor use and dizziness history.
On-Page Visual Blocks For Product Page
Which product images and resources improve conversion and safety?
Include clear product photos of packaging and tablets, a dosing chart, and a printable wallet card for emergency use showing the drug name and contraindications.
Accessibility note — always add alt text, use readable fonts and consider bilingual prompts (English/French) for national reach.
Buying & Storage Advice
In-Store Vs. Online Canadian Purchase Tips
How should Canadians choose where to buy?
In-store purchases allow pharmacists to counsel, check interactions and transfer prescriptions between provincial chains.
Online purchases should be from a licensed Canadian pharmacy, require a valid prescription and follow provincial shipping rules.
Cross-border imports may be cheaper but risk the absence of a Canadian DIN and uncertain supply-chain transparency.
Proper Storage With Canadian Climate Considerations
How to store isosorbide dinitrate at home and when shipping to remote locations?
- Storage — Why It Matters
- Store at room temperature (25°C/77°F), protect from light and humidity, and keep containers tightly closed to preserve potency.
- Shipping Tips — For Remote Provinces/Territories
- Choose expedited, insured shipping to avoid exposure to extreme cold or heat during transit, and avoid leaving medications in vehicles during temperature extremes.
Guidelines For Proper Use
Canadian Doctor/Pharmacist Advice Style
What should clinicians emphasise when counselling patients?
Use shared decision-making to discuss treatment goals — immediate relief versus prevention — and review the nitrate-free interval to reduce tolerance.
Pharmacists should perform medication reconciliation and screen specifically for PDE5 inhibitors and other interacting drugs.
Practical Adherence And Safety Checklists
What practical steps help patients stay safe and adherent?
- Confirm prescription details and correct dosage form (sublingual vs oral).
- Explain dosing schedule and the daily nitrate-free window.
- Advise carrying a wallet card noting the drug, dose and the PDE5 contraindication.
- Encourage reporting adverse effects to the prescriber or Canada Vigilance.
Delivery Across Canada (English)
| City | Region | Delivery Time |
|---|---|---|
| Toronto | Ontario | 5-7 days |
| Montreal | Quebec | 5-7 days |
| Vancouver | British Columbia | 5-7 days |
| Calgary | Alberta | 5-7 days |
| Edmonton | Alberta | 5-7 days |
| Ottawa | Ontario | 5-7 days |
| Winnipeg | Manitoba | 5-7 days |
| Quebec City | Quebec | 5-7 days |
| Halifax | Nova Scotia | 5-9 days |
| Victoria | British Columbia | 5-9 days |
| Hamilton | Ontario | 5-7 days |
| Kitchener | Ontario | 5-7 days |
| London | Ontario | 5-7 days |
| St. John's | Newfoundland and Labrador | 5-9 days |
Closing Practical Notes
What are the final takeaways for Canadians considering isosorbide dinitrate?
Isosorbide dinitrate is a long-standing nitrate used for angina with clear benefits for attack relief and prevention when used correctly.
Pharmacists should prioritise screening for PDE5 inhibitors, counsel on nitrate-free intervals to avoid tolerance and recommend the most appropriate formulation based on attack relief needs and adherence considerations.
Always confirm DIN, manufacturer and provincial coverage at the point of sale to ensure safe dispensing and correct reimbursement.
Report any serious adverse events through provincial channels or Canada Vigilance to support ongoing pharmacovigilance.